Worldwide Image-Guided Biopsy Market Forecast to 2026 | Share, Growth, Industry Analysis, Regional Overview, Size & trends by Top International Players

According to the new market research report " Global Image-Guided Biopsy Market By Technology (X- ray, Ultrasound, Mammograpy, CT, MRI), Process (Fine Needle, Core Needle, Vacuum- Assisted Biopsy), End- User (Hospitals, Ambulatory Surgery Centers, Clinics, Research and Academic Institutes), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026", published by Data Bridge Market Research, the Global Image-Guided Biopsy Market is set to witness a stable CAGR in the forecast period of 2019-2026.

The Global Image-Guided Biopsy Market 2019 Industry report gives a comprehensive account of the Global Image-Guided Biopsy market. Details such as the size, key players, segmentation, SWOT analysis, most influential trends, and business environment of the market are mentioned in this report. Furthermore, this report features tables and figures that render a clear perspective of the Image-Guided Biopsy market

Download PDF Sample Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-image-guided-biopsy-market

This research report segments the Image-Guided Biopsy Market according to Type, Application and regions. It highlights the information about the industries and market, technologies, and abilities over the trends and the developments of the industries. After deep research and analysis by the experts, they also disclosed the data about the strong contenders contributing in the market growth and expansion and challenging one another in terms of demand, supply, production, value estimation, revenue, and sales.

A Image-Guided Biopsy uses low-dose x-rays to diagnose and examine the human breast. The main purpose is the early detection of the breast cancer when it is most treatable. The devices identify mircocalcifications and characteristic of masses. The global aging population specially aged women account for major breast cancer related death to resolve this advance technology demand in mammography is key factor to growth.

Market Drivers:

  • Rising ageing population is driving the growth of this market
  • Technological advancement and development is another factor driving the growth of this market

Market Restraint:

  • High price of the image- guided biopsy is restraining the growth of this market

Along with the elaborated information about the key contenders, the global Image-Guided Biopsy Market report efficiently provides information by segmenting the market on the basis of the type services and products offerings, form of the product, applications of the final products, technology on which the product is based, and others. The report is also bifurcated the market on the basis of regions to analyze the growth pattern of the market in different geographical areas.

Key Developments in the Market:

  • In January 2019, IZI Medical Products, LLC announced that they have acquired Cook Medical’s soft tissue biopsy and breast localization needle assets. IZI is mainly focusing on diagnostic and therapeutic areas with imaging modalities and this acquisition will help them to create better relations with clinicians and physicians who performing the surgeries. It will also help the company to expand their business and sales worldwide.
  • In April 2016, Hologic Inc, announced that they have received FDA clearance for their Affirm prone biopsy system which is the first biopsy system that has 2D and 3D imaging guided Breast biopsies. The main of the launch is to provide innovative solutions to the patient so that they can get better treatment and experience. This also helps the company to expand their breast biopsy portfolio and also healthcare centers to provide minimally invasive breast biopsies.

Browse in-depth TOC on "Image-Guided Biopsy Market"

50 – Tables

250 – No of Figures

150 – Pages

Key Developments in the Market:

In March, 2019, the U.S. Food and Drug Administration announced important step towards the breast cancer screening process as well as to help empower patients by providing important information. The new amendments make it mandatory that screening facilities need to provide detailed information to the patients and healthcare professionals.

In March 2019, according to the ‘National cancer institute’ journal the artificial intelligence system may perform as accurate as radiologists in the evaluation of digital mammography for breast cancer screening.

This Image-Guided Biopsy Market report contains all aspects that are directly or indirectly related to the multiple areas of the global market. Our experts have carefully collated the global Image-Guided Biopsy Market data and estimated the change in the forecast period. This information in the report helps customers make accurate decisions about market activity Image-Guided Biopsy Market based on forecasting trends. This report also discusses current or future policy research or regulations that must be initiated by management and market strategies.

Few Of The Major Competitors Currently Working In The Image-Guided Biopsy Market are Koninklijke Philips N.V., Siemens Healthcare GmbH, Analogic Corporation., GENERAL ELECTRIC, Varian Medical Systems, Inc., Brainlab, Medtronic, Olympus Corporation, KARL STORZ Endoscopy India Pvt. Ltd., Stryker, Hologic, Inc.

Enquire More Before Purchase This Report@ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-image-guided-biopsy-market

Global Image-Guided Biopsy Market Detailed Segmentation:-

By Technology

  • X- ray
  • Ultrasound
  • Mammograpy
  • CT
  • MRI

By Process

  • Fine Needle
  • Core Needle
  • Vacuum- Assisted Biopsy

By End- User

  • Hospitals
  • Ambulatory Surgery Centers
  • Clinics
  • Research and Academic Institutes

The Image-Guided Biopsy Market report includes the leading advancements and technological up-gradation that engages the user to inhabit with fine business selections, define their future-based priority growth plans, and to implement the necessary actions. The global Image-Guided Biopsy Market report also offers a detailed summary of key players and their manufacturing procedure with statistical data and profound analysis of the products, contribution, and revenue.

This report focuses on price, sales, revenue and growth rate of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers. Second on basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Image-Guided Biopsy Market, revenue and market share, for key manufacturers.

Buy This Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-image-guided-biopsy-market

Key Developments in the Market:

On 6th July, 2017, Endo Pharmaceuticals agreed to remove Opana ER (oxymorphone), its abuse-deterrent extended-release formulation of from the US market a month later the US Food and Drug Administration (FDA) asked the company to stop selling the pain medication.

On 19th July 2017, Alere Inc., a global leader in rapid diagnostics, announced the availability of Alere iCup , its point-of-care Rx Drug Screen, a rapid urine test that detects five of the most commonly misused and abused prescription drugs which are benzodiazepines, buprenorphine, methadone, opiates and oxycodone. This innovative approach will help the company to generate more revenue.

Global Image-Guided Biopsy Market Report includes Detailed TOC points:

1 Introduction

  • Objectives Of The Study
  • Market Definition
  • Overview Of Global Image-Guided Biopsy Market
  • Limitations
  • Markets Covered

2Market Segmentation

  • 1 Markets Covered
  • 2 Geographical Scope
  • 3 Years Considered For The Study
  • 4 Currency And Pricing
  • 5 Dbmr Tripod Data Validation Model
  • 6 Multivariate Modelling
  • 7 Products Lifeline Curve
  • 8 Primary Interviews With Key Opinion Leaders
  • 9 DBMR Market Position Grid
  • 1 Vendor Share Analysis
  • 11 Secondary Sources
  • 12 Assumptions

3 Market Overview

  • 1 Drivers
  • .....

3.3 Opportunities

  • 3.1 Rising Government Initiatives
  • 3.2 Strategic Initiative By Market Players
  • 3.3 Rise In Awareness Among The Population
  • 3.4 Growing Healthcare Infrastructure
  • ....

4 Executive Summaries

5 Premium Insights

6 Regulatory Procedure

7 Global Image-Guided Biopsy Market, By Type

8 Global Image-Guided Biopsy Market, by disease type

9 Global Image-Guided Biopsy Market, By Deployment

10 Global Image-Guided Biopsy Market, By End User

11 Global Image-Guided Biopsy Market, By Distribution Channel

12 Global Image-Guided Biopsy Market, By Geography

13 Global Image-Guided Biopsy Market, Company Landscape

  • 1 Company Share Analysis: Global
  • 2 Company Share Analysis: North America
  • 3 company share analysis: Europe
  • 4 company share analysis: Asia-Pacific

14 Company Profile

  • 1.1 Company Snapshot
  • 1.2 Revenue Analysis
  • 1.3 Company Share Analysis
  • 1.4 Product Portfolio
  • 1.5 Recent Development

Continued…!!!

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com